Public interest in the off-label use of glucagon-like peptide 1 agonists (Ozempic) for cosmetic weight loss: A Google Trends analysis, Aesthetic Surgery Journal (2023) Ozempic, DailyMed (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Their lead candidate, ECC5004, is an oral GLP-1 agonist licensed to AstraZeneca for global development (excluding China), while Eccogene retains co-development and co-commercialization rights in China
Visual inspection Clear solution should remain clear: Any cloudiness = discard Particles floating = discard Color change = discard (especially important for copper peptides) Separation or layers = discard Exception: Some peptides may have slight natural color
The complete list with gene symbols, compound names, and IDs (Ensembl protein IDs and Compound IDs, resp.,) is additionally provided (see Supporting Information Tables S1, S2, and S3 available online at For elucidating the topological network properties, Cytoscape ( an open source platform for complex network analysis and visualization, was used [20]